020

Price range: $70.00 through $180.00

Contac us Now
Option10mg*10vials, 50mg*10vials

Description

【Name】
Generic Name: EpitalonTrade Name: qiqipeptide Epitalon Peptide
【Specification】
10mg/vial or 50mg/vial (lyophilized powder form. containing mannitol excipients)
【Chemical Information】
CAS Number: 307297-39-8Molecular Weight: 388.42 g/molMolecular Formula: C₁₄H₂₂N₈O₄Amino Acid Sequence: Ala-      Glu-Asp-Gly
【Research Applications】
Research on aging mechanisms: Induces telomerase activity to extend telomere length. used in experiments on cellular aging models (e.g.. human fibroblasts);Neuroendocrine regulation: Restores melatonin synthesis and cortisol circadian rhythm in elderly macaque models. used in mechanism studies of neurodegenerative diseases (e.g.. Alzheimer’s disease);Research on antioxidant stress: Upregulates the expression of antioxidant enzymes such as superoxide dismutase (SOD). used in cell/animal experiments related to oxidative damage;Circadian rhythm regulation: Extends maximum lifespan in rat models under constant light. used in molecular mechanism studies of circadian rhythm disorders.
【Physical Properties】
Appearance: White lyophilized powderSolubility: Easily soluble in sterile water or 0.9% sodium chloride solution   (suggested   concentration ≥ 50μg/ml)
【Storage Conditions】
Unopened: Store at 2~8°C protected from light; long-term storage requires -20°C or lower;After reconstitution: Stable for    3~5 days when stored at 4°C; can be extended to 2~3 months when aliquoted and frozen at -20°C (avoid repeated freeze-  thaw cycles).
【Safety Warnings】
For research use only: This product is a research peptide and is prohibited for human use (injection. oral administration.   external use) or animal consumption;Operational protection: Wear gloves and goggles during handling to avoid inhalation   or  contact with skin/mucous membranes;Legal compliance: Must comply with the import/sales regulations for research   peptides in the target market (e.g.. FDA’s IND exemption requirements in the United States. management of research   substances under the EU’s General Pharmaceutical Regulation).